Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

100.0%

8 terminated/withdrawn out of 8 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

6 terminated

Enrollment Performance

Analytics

Phase 1

8(100.0%)

8Total

Phase 1(8)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00278577Phase 1Terminated

Hematopoietic Stem Cell Support in Patients With Severe Crohn's Disease

Role: lead

NCT01019681Phase 1Terminated

Efficacy and Safety of Umbilical Cord Blood Injection for Critical Limb Ischemia

Role: lead

NCT00278551Phase 1Terminated

Stem Cell Support in Patients With Rheumatoid Arthritis

Role: lead

NCT00278486Phase 1Terminated

Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)

Role: lead

NCT00278642Phase 1Terminated

Hematopoietic Stem Cell Support in Patients With Autoimmune Bullous Skin Disorders

Role: lead

NCT00282425Phase 1Terminated

Allogeneic Hematopoietic Stem Cell Transplantation (NST) for Patients With Systemic Sclerosis

Role: lead

NCT00393185Phase 1Withdrawn

Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis

Role: lead

NCT00278616Phase 1Withdrawn

Hematopoietic Stem Cell Transplantation in Patients With Antiphospholipid Syndrome

Role: lead

All 8 trials loaded